Glenmark Pharma’s Indore unit gets USFDA warning letter; Stock in F&O ban

Shares of Glenmark Pharma are in F&O ban on Monday, July 14, which means no new positions can be created in the stock.

Leave a Reply

Your email address will not be published. Required fields are marked *